These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 31989448

  • 1. Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.
    Algburi A, Alazzawi SA, Al-Ezzy AIA, Weeks R, Chistyakov V, Chikindas ML.
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1471-1483. PubMed ID: 31989448
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
    Wasfi R, Abd El-Rahman OA, Mansour LE, Hanora AS, Hashem AM, Ashour MS.
    Indian J Med Microbiol; 2012 Dec; 30(1):76-80. PubMed ID: 22361765
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.
    Shikh-Bardsiri H, Shakibaie MR.
    Pak J Biol Sci; 2013 Nov 15; 16(22):1496-502. PubMed ID: 24511691
    [Abstract] [Full Text] [Related]

  • 5. Assessment of Biofilm Forming Capability and Antibiotic Resistance in Proteus mirabilis Colonizing Indwelling Catheter.
    Egbule OS, Konye OP, Iweriebor BC.
    Pak J Biol Sci; 2024 Apr 15; 27(5):268-275. PubMed ID: 38840467
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial and Anti-Biofilm Activity of Polymyxin E Alone and in Combination with Probiotic Strains of Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 against Clinical Isolates of Selected Acinetobacter spp.: A Preliminary Study.
    Al-Dulaimi M, Algburi A, Abdelhameed A, Mazanko MS, Rudoy DV, Ermakov AM, Chikindas ML.
    Pathogens; 2021 Dec 02; 10(12):. PubMed ID: 34959528
    [Abstract] [Full Text] [Related]

  • 7. Subtilosin Prevents Biofilm Formation by Inhibiting Bacterial Quorum Sensing.
    Algburi A, Zehm S, Netrebov V, Bren AB, Chistyakov V, Chikindas ML.
    Probiotics Antimicrob Proteins; 2017 Mar 02; 9(1):81-90. PubMed ID: 27914001
    [Abstract] [Full Text] [Related]

  • 8. Copper affects virulence and diverse phenotypes of uropathogenic Proteus mirabilis.
    Huang WS, Lee YJ, Wang L, Chen HH, Chao YJ, Cheng V, Liaw SJ.
    J Microbiol Immunol Infect; 2024 Jun 02; 57(3):385-395. PubMed ID: 38453541
    [Abstract] [Full Text] [Related]

  • 9. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J, Bogiel T, Gospodarek E.
    J Antibiot (Tokyo); 2013 Oct 02; 66(10):593-7. PubMed ID: 23801185
    [Abstract] [Full Text] [Related]

  • 10. Catalase Activity is Critical for Proteus mirabilis Biofilm Development, Extracellular Polymeric Substance Composition, and Dissemination during Catheter-Associated Urinary Tract Infection.
    White AN, Learman BS, Brauer AL, Armbruster CE.
    Infect Immun; 2021 Sep 16; 89(10):e0017721. PubMed ID: 34280035
    [Abstract] [Full Text] [Related]

  • 11. [Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
    Cernohorská L, Chvílová E.
    Klin Mikrobiol Infekc Lek; 2011 Jun 16; 17(3):81-5. PubMed ID: 21780025
    [Abstract] [Full Text] [Related]

  • 12. SOS Response Inhibitory Properties by Potential Probiotic Formulations of Bacillus amyloliquefaciens B-1895 and Bacillus subtilis KATMIRA1933 Obtained by Solid-State Fermentation.
    Prazdnova EV, Mazanko MS, Bren AB, Chistyakov VA, Weeks R, Chikindas ML.
    Curr Microbiol; 2019 Mar 16; 76(3):312-319. PubMed ID: 30603963
    [Abstract] [Full Text] [Related]

  • 13. Elimination of multidrug-resistant Proteus mirabilis biofilms using bacteriophages.
    Gomaa S, Serry F, Abdellatif H, Abbas H.
    Arch Virol; 2019 Sep 16; 164(9):2265-2275. PubMed ID: 31197549
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of inhibitory activity of domestic probiotics for against invasion and infection by Proteus mirabilis in the urinary tract.
    Lai TM, Lin PP, Hsieh YM, Tsai CC.
    J Infect Dev Ctries; 2020 Apr 30; 14(4):366-372. PubMed ID: 32379713
    [Abstract] [Full Text] [Related]

  • 15. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
    Fusco A, Coretti L, Savio V, Buommino E, Lembo F, Donnarumma G.
    Int J Mol Sci; 2017 Feb 15; 18(2):. PubMed ID: 28212280
    [Abstract] [Full Text] [Related]

  • 16. Bacillus subtilis-derived peptides disrupt quorum sensing and biofilm assembly in multidrug-resistant Staphylococcus aureus.
    Leistikow KR, May DS, Suh WS, Vargas Asensio G, Schaenzer AJ, Currie CR, Hristova KR.
    mSystems; 2024 Aug 20; 9(8):e0071224. PubMed ID: 38990088
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alhagi maurorum extract modulates quorum sensing genes and biofilm formation in Proteus mirabilis.
    Mirzaei A, Nasr Esfahani B, Ghanadian M, Moghim S.
    Sci Rep; 2022 Aug 17; 12(1):13992. PubMed ID: 35978046
    [Abstract] [Full Text] [Related]

  • 20. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R, Okugawa S, Kumita W, Sato K, Chida T, Okamura N, Moriya K, Koike K.
    Clin Microbiol Infect; 2007 Dec 17; 13(12):1204-6. PubMed ID: 17850340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.